ArticleMolecular diversity2026

Rational in silico design of PPARγ agonists for type 2 diabetes: an integrated study using pharmacophore modeling, 3D-QSAR, molecular docking, MD simulations, DFT, and toxicity prediction.

Tathagata Pradhan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.